Arachidonic acid metabolism in glutathione-deficient macrophages

Proc Natl Acad Sci U S A. 1982 Mar;79(5):1621-5. doi: 10.1073/pnas.79.5.1621.

Abstract

Mouse resident peritoneal macrophages were treated with the glutathione (GSH) synthesis inhibitor buthionine sulfoximine to deplete intracellular GSH. The arachidonic acid metabolites released by the GSH-depleted macrophages in response to a zymosan challenge were analyzed by HPLC. Buthionine sulfoximine treatment resulted in inhibition of both prostaglandin E2 and leukotriene C synthesis that was directly related to the degree of GSH depletion. Macrophages in which GSH levels were reduced to 3% of normal exhibited reductions to 4% and 1%, respectively, in PGE2 and LTC formation. The total quantity of cyclooxygenase metabolites secreted by GSH-deficient macrophages was identical to that of control cells as a result of increased synthesis of prostacyclin and, to a lesser extent, 12-L-hydroxy-5,8,10-heptadecatrienoic acid. Total lipoxygenase products were decreased, however; increased formation of hydroxyicosatetraenoic acids only partially compensated for the deficit in leukotriene C production. These findings extent our earlier observations on the inhibition of leukotriene C synthesis in GSH-depleted macrophages and confirm with intact cells the previously suggested role of GSH in prostaglandin E2 formation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Arachidonic Acid
  • Arachidonic Acids / metabolism*
  • Cell Survival
  • Epoprostenol / biosynthesis*
  • Glutathione / deficiency*
  • Macrophages / metabolism*
  • Phagocytosis
  • Prostaglandins / biosynthesis*
  • Prostaglandins E / biosynthesis*
  • Zymosan

Substances

  • Arachidonic Acids
  • Prostaglandins
  • Prostaglandins E
  • Arachidonic Acid
  • Zymosan
  • Epoprostenol
  • Glutathione